These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20375240)

  • 1. Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.
    Holbeck S; Chang J; Best AM; Bookout AL; Mangelsdorf DJ; Martinez ED
    Mol Endocrinol; 2010 Jun; 24(6):1287-96. PubMed ID: 20375240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
    Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
    Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer.
    Muscat GE; Eriksson NA; Byth K; Loi S; Graham D; Jindal S; Davis MJ; Clyne C; Funder JW; Simpson ER; Ragan MA; Kuczek E; Fuller PJ; Tilley WD; Leedman PJ; Clarke CL
    Mol Endocrinol; 2013 Feb; 27(2):350-65. PubMed ID: 23292282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.
    Jeong Y; Xie Y; Lee W; Bookout AL; Girard L; Raso G; Behrens C; Wistuba II; Gadzar AF; Minna JD; Mangelsdorf DJ
    Mol Endocrinol; 2012 Aug; 26(8):1443-54. PubMed ID: 22700587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
    Vienonen A; Miettinen S; Manninen T; Altucci L; Wilhelm E; Ylikomi T
    Eur J Endocrinol; 2003 Apr; 148(4):469-79. PubMed ID: 12656669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
    Hayashi N; Nakamori S; Hiraoka N; Tsujie M; Xundi X; Takano T; Amino N; Sakon M; Monden M
    Int J Oncol; 2004 Jan; 24(1):89-95. PubMed ID: 14654945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer.
    Lin ML; Patel H; Remenyi J; Banerji CR; Lai CF; Periyasamy M; Lombardo Y; Busonero C; Ottaviani S; Passey A; Quinlan PR; Purdie CA; Jordan LB; Thompson AM; Finn RS; Rueda OM; Caldas C; Gil J; Coombes RC; Fuller-Pace FV; Teschendorff AE; Buluwela L; Ali S
    Oncotarget; 2015 Aug; 6(25):21685-703. PubMed ID: 26280373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters.
    Okabe M; Szakács G; Reimers MA; Suzuki T; Hall MD; Abe T; Weinstein JN; Gottesman MM
    Mol Cancer Ther; 2008 Sep; 7(9):3081-91. PubMed ID: 18790787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene expression profiles in the diagnosis and prognosis of cancer].
    Kopper L; Tímár J
    Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen.
    Covell DG
    PLoS One; 2012; 7(10):e44631. PubMed ID: 23056181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
    Burgermeister E; Tencer L; Liscovitch M
    Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.
    Mishra DK; Chen Z; Wu Y; Sarkissyan M; Koeffler HP; Vadgama JV
    Mol Cancer Ther; 2010 Jan; 9(1):33-45. PubMed ID: 20053773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.
    Moretti RM; Marelli MM; Motta M; Polizzi D; Monestiroli S; Pratesi G; Limonta P
    Prostate; 2001 Mar; 46(4):327-35. PubMed ID: 11241556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression pattern of nuclear receptors during cerebellar development.
    Qin J; Suh JM; Kim BJ; Yu CT; Tanaka T; Kodama T; Tsai MJ; Tsai SY
    Dev Dyn; 2007 Mar; 236(3):810-20. PubMed ID: 17205580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression signature of invasive potential in metastatic melanoma cells.
    Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR
    PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer network activity associated with therapeutic response and synergism.
    Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
    Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.